Literature DB >> 8379801

The impact and cost of influenza in the elderly.

A M McBean1, J D Babish, J L Warren.   

Abstract

BACKGROUND: Traditional methods of measuring the impact and cost of influenza virus have focused on epidemic years and morbidity and mortality due to pneumonia and influenza.
METHODS: Annualized age-sex-race adjusted rates of hospitalization for pneumonia and influenza and other diagnoses among elderly Medicare beneficiaries during the epidemic influenza season of 1989 to 1990 and the nonepidemic season of 1990 to 1991 were compared with an interim period in 1990 without influenza virus circulation.
RESULTS: The rates of hospitalization for pneumonia and influenza, acute bronchitis, chronic respiratory disease, and congestive heart failure were significantly greater during each influenza period compared with the interim period. The highest rates were found in the epidemic season of 1989 to 1990. The amount reimbursed by Medicare to hospitals to 1990. The amount reimbursed by Medicare to hospitals for the treatment of excess hospitalizations during periods of influenza activity was more than $1 billion in 1989 to 1990 and almost $750 million in 1990 to 1991.
CONCLUSIONS: Measures of the impact and cost of influenza in elderly Americans should include all of the diagnoses listed above and should recognize that the impact of influenza virus is significant even in nonepidemic years. There are great opportunities for cost savings if effective control programs are implemented.

Entities:  

Mesh:

Year:  1993        PMID: 8379801

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  28 in total

1.  Measuring the impact of influenza on the hospital admission rates of the elderly in Ontario: a five-year admission rate analysis, 1988-1993.

Authors:  R E Upshur; V Goel
Journal:  Can J Public Health       Date:  2000 Mar-Apr

Review 2.  Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.

Authors:  M J Postma; R M Baltussen; M L Heijnen; L T de Berg; J C Jager
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

3.  The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality.

Authors:  Verena H Menec; Charlyn Black; Leonard MacWilliam; Fred Y Aoki
Journal:  Can J Public Health       Date:  2003 Jan-Feb

4.  Economic evaluation of influenza vaccination and economic modelling. Can results be pooled?

Authors:  T Jefferson; V Demicheli
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

Review 5.  Evaluating the impact of influenza vaccination. A North American perspective.

Authors:  D S Fedson
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

6.  The causes of racial and ethnic differences in influenza vaccination rates among elderly Medicare beneficiaries.

Authors:  Paul L Hebert; Kevin D Frick; Robert L Kane; A Marshall McBean
Journal:  Health Serv Res       Date:  2005-04       Impact factor: 3.402

Review 7.  The value of influenza and pneumococcal vaccines in the elderly.

Authors:  A S Monto; M S Terpenning
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

8.  Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals.

Authors:  J J Goronzy; J W Fulbright; C S Crowson; G A Poland; W M O'Fallon; C M Weyand
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 9.  The economic impact of pandemic influenza in the United States: priorities for intervention.

Authors:  M I Meltzer; N J Cox; K Fukuda
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

10.  Medical care capacity for influenza outbreaks, Los Angeles.

Authors:  Carol A Glaser; Sabrina Gilliam; William W Thompson; David E Dassey; Stephen H Waterman; Mitchell Saruwatari; Stanley Shapiro; Keiji Fukuda
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.